Get ready to mark your calendars because the much anticipated third quarter financial results of Jazz Pharmaceuticals plc (NASDAQ: JAZZ) are set to be unveiled on Wednesday 6th November 2024. Investors and market watchers will have the chance to dive into the company's financial performance as the announcement is scheduled after market close.
Wall Street financial analysts are foreseeing that the company is likely to announce an estimated per share $5.50 profit for the quarter. Furthermore, it is anticipated that the company will disclose a total revenue of $1.04 billion during the quarter.
In the same three months of the year before, the company made income of $4.84 per share, as shown in their financial report. This number came from the total revenue of $972.14 million that the company earned in that particular quarter.
Analysts on Wall Street have shared their predictions regarding the annual performance of the company, estimating a total revenue of $4.04 billion. Additionally, they are expecting the company to achieve per share profit of $19.59 for the fiscal year.
Additionally, The company will host a conference call with investors and analysts on 6th November 2024 at 04:30 PM eastern time to review the Q3 2024 financial results.
Jazz Pharmaceuticals plc (JAZZ) closed Friday's regular trading session at $110.45, demonstrating a 0.38 percent rise. The stock fluctuated between $109.89 and $111.23 during the day, with a volume of 369.70 thousand shares.
